Science Explained
Lab guides, compound files and side-by-side comparisons. Written for researchers, with sources.
Science Explained
7 shownScience ExplainedScience ExplainedGrowth Hormone Secretagogues: GHRH, Ghrelin, and the GH AxisMap the signals behind growth hormone release, distinguish GHRH from ghrelin-receptor strategies, and interpret hormone measurements without turning them into broad outcome claims.5 min readScience ExplainedScience ExplainedCopper Peptides in Tissue Research: GHK, Complexes, and EvidenceSeparate the GHK peptide from its copper complex, read tissue-model findings in context, and understand why formulation identity matters in laboratory comparisons.5 min readScience ExplainedScience ExplainedOrforglipron Explained: An Oral GLP-1 Agonist That Is Not a PeptideExplore orforglipron’s nonpeptide design, receptor studies, clinical evidence, and April 2026 FDA approval while distinguishing it from semaglutide research material.5 min readScience ExplainedScience ExplainedGLP-1 and Lean Mass: Reading Body-Composition Research ClearlyInterpret semaglutide and tirzepatide body-composition findings without equating DXA lean mass with skeletal muscle, strength, or the proportion of weight lost.5 min readScience ExplainedScience ExplainedGLP-1 and Fatty Liver Research: MASLD, MASH, and FibrosisRead metabolic liver research by separating imaging, inflammation, fibrosis, and clinical outcomes, with context for semaglutide’s specific accelerated MASH approval.5 min readScience ExplainedScience ExplainedResearch Use Only Peptides: Labels, Evidence, and Laboratory ScopeUnderstand what a research-use label does and does not establish, how to evaluate analytical documentation, and why clinical evidence and product approval remain separate.5 min readScience ExplainedScience ExplainedSurvodutide and Mazdutide: The GLP-1 and Glucagon Research StrategyCompare GLP-1/glucagon dual-agonist research while separating individual molecules, trial designs, current regional status, and the distinct GIP/GLP-1 tirzepatide strategy.5 min read